BETHESDA, Md., Jan. 29, 2013 /PRNewswire/ – Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Dr. Marnix Bosch, the Company’s Chief Technical Officer, will be…

PR Newswire: Health